Back

Suppression of Wnt signalling in a desmoglein-2 transgenic mouse model for arrhythmogenic cardiomyopathy

10 July 2016 (08:30 - 17:00)
Organised by: Logo
Congress Presentation Part of: Poster session 3 - Cardiomyopathies and fibrosis Cardiomyopathies Open Access Frontiers in CardioVascular Biology 2016 Council on Basic Cardiovascular Science

About the speaker

Photo
Doctor Alessandra Lorenzon

Padua (Italy)

11 More presentations in this session

Presentation thumbnail
Presentation thumbnail
Presentation thumbnail
Miss C. Ruperez (Barcelona, ES)
Abstract
Presentation thumbnail
Ms L. Woudstra (Amsterdam, NL)
Abstract
Presentation thumbnail
Mrs N. Suffee (Paris, FR)
Abstract

Access the full session

Session thumbnail
Poster session 3 - Cardiomyopathies and fibrosis

The Event

Event poster

Frontiers in CardioVascular Biology 2016

10 July 2016 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Pathogenic mechanism of DSG2-F531C mutation caused arrhythmogenic right ventricular cardiomyopathy
3 September 2019
thumbnail
Congress Presentation
Stage specific effects of insulin and Wnt on cell fate decisions in human induced pluripotent stem cell-derived cardiomyocytes
12 April 2024
thumbnail
Congress Presentation
The role of Wnt signaling in development of coronary artery disease: WNT1 protein in patients with obstructive and non-obstructive coronary artery disease
29 August 2025
thumbnail
Congress Presentation
Conditional ablation of SDF-1/CXCL12 in smooth muscle cells leads to severe cardiac hypertrophy and aortic valve stenosis
3 September 2019

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources